Palladone Related Published Studies
Well-designed clinical trials related to Palladone (Hydromorphone)
The side effects of morphine and hydromorphone patient-controlled analgesia. [2008.10]
Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline. [2008.07]
Relief of Incident Dyspnea in Palliative Cancer Patients: A Pilot, Randomized, Controlled Trial Comparing Nebulized Hydromorphone, Systemic Hydromorphone, and Nebulized Saline. [2008.03.19]
Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain. [2008.03]
Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol. [2008.01]
Metoclopramide versus hydromorphone for the emergency department treatment of migraine headache. [2008.01]
Metoclopramide Versus Hydromorphone for the Emergency Department Treatment of Migraine Headache. [2007.11.02]
A comparison of single-dose caudal clonidine, morphine, or hydromorphone combined with ropivacaine in pediatric patients undergoing ureteral reimplantation. [2007.06]
Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis. [2007.05]
Dose-related thermal antinociceptive effects of intravenous hydromorphone in cats. [2007.03]
Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone. [2007.02.02]
Safety and efficacy of hydromorphone as an analgesic alternative to morphine in acute pain: a randomized clinical trial. [2006.08]
Effects of oxymorphone and hydromorphone on the minimum alveolar concentration of isoflurane in dogs. [2006.01]
Comparative efficacy of oral extended-release hydromorphone and immediate-release hydromorphone in patients with persistent moderate to severe pain: two randomized controlled trials. [2005.06]
Clinical pharmacology and pharmacokinetics of once-daily hydromorphone hydrochloride extended-release capsules. [2005.05]
Well-designed clinical trials possibly related to Palladone (Hydromorphone)
Brain dopamine response in human opioid addiction. [2008.07]
Effect of orally administered tramadol alone or with an intravenously administered opioid on minimum alveolar concentration of sevoflurane in cats. [2008.06.15]
A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain. [2008.05]
The use of dexamethasone to reduce pain after tonsillectomy in adults: a double-blind prospective randomized trial. [2008.02]
Ketamine as an adjunct to postoperative pain management in opioid tolerant patients after spinal fusions: a prospective randomized trial. [2008.02]
Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial. [2008.01]
Femoral nerve block for diaphyseal and distal femoral fractures in the emergency department. [2007.12]
The Use of Dexamethasone to Reduce Pain After Tonsillectomy in Adults: A Double-Blind Prospective Randomized Trial. [2007.11.26]
Randomized trial comparing 3 methods of postoperative analgesia in gynecology patients: patient-controlled intravenous, scheduled intravenous, and scheduled subcutaneous. [2007.11]
Mapping MOS Sleep Scale scores to SF-6D utility index. [2007.09]
Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial. [2007.06]
The effects of surgery and anesthesia on blood magnesium and calcium concentrations in canine and feline patients. [2007.03]
Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices. [2007.01.01]
A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. [2007.01]
Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period. [2006.12]
The effect of nitrous oxide on halothane, isoflurane and sevoflurane requirements in ventilated dogs undergoing ovariohysterectomy. [2006.11]
Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of unit price and pre-session drug supply. [2006.10.15]
Continuous femoral nerve block versus intra-articular injection for pain control after anterior cruciate ligament reconstruction. [2006.08]
A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. [2006.03]
Evaluation of a single-dose, extended-release epidural morphine formulation for pain after knee arthroplasty. [2006.02]
Comparison of oxycodone pharmacokinetics after buccal and sublingual administration in children. [2006]
Efficacy and safety of oxymorphone immediate release for the treatment of mild to moderate pain after ambulatory orthopedic surgery: results of a randomized, double-blind, placebo-controlled trial. [2005.12]
A prospective, randomized, double-blind study evaluating the efficacy of postoperative continuous local anesthetic infusion at the iliac crest bone graft site after spinal arthrodesis. [2005.11.15]
The effect of preemptive pudendal nerve blockade on pain after transvaginal pelvic reconstructive surgery. [2005.10]
Oxymorphone Extended-Release Tablets Relieve Moderate to Severe Pain and Improve Physical Function in Osteoarthritis: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Trial. [2005.09]
The effects of femoral nerve blockade in conjunction with epidural analgesia after total knee arthroplasty. [2005.09]
Acetaminophen decreases early post-thoracotomy ipsilateral shoulder pain in patients with thoracic epidural analgesia: a double-blind placebo-controlled study. [2005.08]
Efficacy of continuous local anesthetic infusion for postoperative pain after radical retropubic prostatectomy. [2005.08]
Comparison of perioperative analgesic protocols for dogs undergoing tibial plateau leveling osteotomy. [2005.07]
Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways. [2005.03]
The risk of cesarean delivery with neuraxial analgesia given early versus late in labor. [2005.02.17]
Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. [2005.01]
Single- and multiple-dose pharmacokinetic and dose-proportionality study of oxymorphone immediate-release tablets. [2005]
Other research related to Palladone (Hydromorphone)
The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers. [2008.12.01]
Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer pain. [2008.09]
Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs. [2008.08]
The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers. [2008.07.07]
Edema caused by continuous epidural hydromorphone infusion: a case report and review of the literature. [2008.07]
The detection of hydromorphone in urine specimens with high morphine concentrations. [2008.05]
Cardiopulmonary effects of anesthetic induction with thiopental, propofol, or a combination of ketamine hydrochloride and diazepam in dogs sedated with a combination of medetomidine and hydromorphone. [2008.05]
Pharmacokinetics of hydromorphone hydrochloride in healthy dogs. [2008.05]
Intrathecal granuloma in a patient receiving high dose hydromorphone. [2008.05]
Evidence that morphine is metabolized to hydromorphone but not to oxymorphone. [2008.05]
Comparison of the analgesic efficacy of hydromorphone and oxymorphone in dogs and cats: a randomized blinded study. [2008.03.18]
Opioid withdrawal syndrome on switching from hydromorphone to alfentanil. [2008.03]
Pharmacokinetics of hydromorphone hydrochloride in healthy dogs. [2008.02.18]
Effect of hydromorphone on ventilation in palliative care patients with dyspnea. [2008.01]
Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs. [2007.12]
Successful reduction of neuropathic pain associated with spinal cord injury via of a combination of intrathecal hydromorphone and ziconotide: a case report. [2007.11]
Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study. [2007.10]
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone. [2007.10]
[Pharmacotherapy of chronic, non-tumour related pain. Efficacy, tolerability and patient benefit of an oral osmotic system with hydromorphone] [2007.09.13]
Use of hydromorphone (Dilaudid) and morphine for patients with hepatic and renal impairment. [2007.07]
Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO-127). [2007.05]
Clinical Trial Results with OROS((R)) Hydromorphone. [2007.02]
Correlates of nonmedical use of hydromorphone and hydrocodone:results from a national household survey. [2007]
Hydromorphone in the management of cancer-related pain: an update on routes of administration and dosage forms. [2007]
A single dose of liposome-encapsulated hydromorphone provides extended analgesia in a rat model of neuropathic pain. [2006.12]
Postanesthetic hyperthermia in cats: a retrospective comparison between hydromorphone and buprenorphine. [2006.11]
Managing Cancer Pain and Symptoms of Outpatients by Rotation to Sustained-release Hydromorphone: A Prospective Clinical Trial. [2006.11]
A myoclonic reaction with low-dose hydromorphone. [2006.11]
Hydromorphone-related fatalities in ontario. [2006.04]
Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine. [2006.01]
Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study. [2006.01]
Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain. [2006.01]
[Controlled-release hydromorphone in elderly patients with severe pain of different etiologies. Results of an observational study] [2005.10.06]
Evaluation of induction by use of a combination of oxymorphone and diazepam or hydromorphone and diazepam and maintenance of anesthesia by use of isoflurane in dogs with experimentally induced hypovolemia. [2005.07]
GC-MS quantitation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in blood. [2005.07]
The metamorphosis of hydromorphone. [2005.07]
Hydromorphone. [2005.05]
Other possibly related research studies
Post-anesthetic hyperthermia in cats. [2007.01]
Equianalgesic dosing of opioids. [2006]
Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats. [2006.10]
Post-dural headache associated with thoracic paravertebral blocks. [2006.08]
Anesthesia and pain management for pediatric patients with dystrophic epidermolysis bullosa. [2006.06]
Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. [2005.11]
Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery. [2006.03.20]
Oxymorphone: a review. [2006.02]
Protracted pain following partial splenic embolization in an adolescent female with hypersplenism. [2005.11]
Postoperative pain management following bilateral lung volume reduction surgery for severe emphysema. [2005.10]
Postoperative day one: a high risk period for respiratory events. [2005.11]
Pain evaluation in patients receiving intravenous patient-controlled analgesia after surgery. [2005.09]
Opioid switch in palliative care, opioid choice by clinical need and opioid availability. [2005.10]
Perioperative management of a child with short-chain acyl-CoA dehydrogenase deficiency. [2005.09]
Eliminating analgesic meperidine use with a supported formulary restriction. [2005.08]
Rotation to methadone after opioid dose escalation: How should individualization of dosing occur? [2005]
|
